Literature DB >> 16120421

Mitochondrial dysfunction and possible treatments in Parkinson's disease--a review.

Clifford W Shults1.   

Abstract

Mitochondria are central not only to the bioenergetics of the cell but also to the process of apoptotic cell death. Substantial data indicate mitochondrial dysfunction, particularly of complex I of the electron transport chain, in some patients with Parkinson's disease (PD), and it appears likely that mitochondria contribute to the pathogenic processes that occurs in this disorder. Treatments targeted at mitochondrial function hold promise to slow the progression of PD.

Entities:  

Year:  2004        PMID: 16120421     DOI: 10.1016/j.mito.2004.07.028

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  9 in total

Review 1.  Parkin and PINK1 functions in oxidative stress and neurodegeneration.

Authors:  Sandeep K Barodia; Rose B Creed; Matthew S Goldberg
Journal:  Brain Res Bull       Date:  2016-12-23       Impact factor: 4.077

Review 2.  Oxygenomics in environmental stress.

Authors:  H Sone; H Akanuma; T Fukuda
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

3.  Lewy bodies.

Authors:  Clifford W Shults
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-31       Impact factor: 11.205

4.  Relationships among molecular genetic and respiratory properties of Parkinson's disease cybrid cells show similarities to Parkinson's brain tissues.

Authors:  M Kathleen Borland; K P Mohanakumar; Jeremy D Rubinstein; Paula M Keeney; Jing Xie; Roderick Capaldi; Lisa D Dunham; Patricia A Trimmer; James P Bennett
Journal:  Biochim Biophys Acta       Date:  2008-10-10

5.  Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease.

Authors:  Emma Thornton; Robert Vink
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

Review 6.  Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation Products.

Authors:  Giuseppina Barrera; Fabrizio Gentile; Stefania Pizzimenti; Rosa Angela Canuto; Martina Daga; Alessia Arcaro; Giovanni Paolo Cetrangolo; Alessio Lepore; Carlo Ferretti; Chiara Dianzani; Giuliana Muzio
Journal:  Antioxidants (Basel)       Date:  2016-02-19

7.  Mitochondrial nutrition as a strategy for neuroprotection in Parkinson's disease—research focus in the department of alternative medicine and experimental therapeutics at Hokuriku University.

Authors:  Yasuhide Mitsumoto
Journal:  Evid Based Complement Alternat Med       Date:  2007-06       Impact factor: 2.629

Review 8.  Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development.

Authors:  Stuart P McCluskey; Christophe Plisson; Eugenii A Rabiner; Oliver Howes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-21       Impact factor: 9.236

9.  Visualizing Dynamic Performance of Lipid Droplets in a Parkinson's Disease Model via a Smart Photostable Aggregation-Induced Emission Probe.

Authors:  Lihua Li; Fan Zhou; Qun Gao; Yao Lu; Xingyi Xu; Rong Hu; Zhiming Wang; Mingying Peng; Zhongmin Yang; Ben Zhong Tang
Journal:  iScience       Date:  2019-10-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.